Corient Private Wealth LP Sells 16,098 Shares of GE HealthCare Technologies Inc. $GEHC

Corient Private Wealth LP lowered its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 22.1% in the second quarter, Holdings Channel.com reports. The institutional investor owned 56,596 shares of the company’s stock after selling 16,098 shares during the period. Corient Private Wealth LP’s holdings in GE HealthCare Technologies were worth $3,624,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of GEHC. Godfrey Financial Associates Inc. acquired a new position in GE HealthCare Technologies during the fourth quarter worth about $27,000. Montag A & Associates Inc. lifted its holdings in shares of GE HealthCare Technologies by 105.4% in the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after acquiring an additional 175 shares during the last quarter. Transamerica Financial Advisors LLC boosted its stake in shares of GE HealthCare Technologies by 331.6% in the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 262 shares in the last quarter. Physician Wealth Advisors Inc. grew its holdings in shares of GE HealthCare Technologies by 60.4% during the 1st quarter. Physician Wealth Advisors Inc. now owns 433 shares of the company’s stock valued at $31,000 after purchasing an additional 163 shares during the last quarter. Finally, MV Capital Management Inc. bought a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at approximately $33,000. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Down 1.1%

GEHC opened at $70.42 on Wednesday. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.26 and a quick ratio of 0.97. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The company’s 50 day moving average price is $68.02 and its two-hundred day moving average price is $69.14. The firm has a market capitalization of $31.81 billion, a price-to-earnings ratio of 16.15, a PEG ratio of 1.88 and a beta of 0.70.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The firm had revenue of $5.29 billion during the quarter, compared to the consensus estimate of $5.26 billion. During the same quarter last year, the firm earned $1.06 earnings per share. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.93 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Friday, July 24th were given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date was Friday, July 24th. GE HealthCare Technologies’s payout ratio is 3.21%.

Wall Street Analyst Weigh In

Several equities analysts recently commented on GEHC shares. Piper Sandler reissued a “buy” rating on shares of GE HealthCare Technologies in a research note on Wednesday, July 29th. Royal Bank Of Canada began coverage on shares of GE HealthCare Technologies in a research note on Tuesday, June 23rd. They set an “outperform” rating and a $80.00 target price on the stock. BTIG Research reiterated a “buy” rating and set a $79.00 price target on shares of GE HealthCare Technologies in a report on Wednesday, August 19th. Weiss Ratings reiterated a “hold (c-)” rating on shares of GE HealthCare Technologies in a research note on Wednesday, August 12th. Finally, BMO Capital Markets initiated coverage on GE HealthCare Technologies in a report on Wednesday, July 8th. They set a “market perform” rating and a $70.00 price objective on the stock. Ten equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Hold” and a consensus target price of $77.73.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.